Have you ever wished to drive microscopic matter along an arbitrarily tailored trajectory instead of just a circle? That's exactly what we set out to achieve.

Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

March 30, 2026 • All children, regardless of immigration status, have the right to a free K-12 public education. But without birthright citizenship, access to schools and colleges could get ...